KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Times Interest Earned (2017 - 2022)

Historic Times Interest Earned for Sarepta Therapeutics (SRPT) over the last 6 years, with Q4 2022 value amounting to -$15.97.

  • Sarepta Therapeutics' Times Interest Earned fell 6851.98% to -$15.97 in Q4 2022 from the same period last year, while for Sep 2023 it was -$59.7, marking a year-over-year decrease of 57071.48%. This contributed to the annual value of -$12.17 for FY2023, which is 2083.84% down from last year.
  • Latest data reveals that Sarepta Therapeutics reported Times Interest Earned of -$15.97 as of Q4 2022, which was down 6851.98% from -$8.91 recorded in Q3 2022.
  • Sarepta Therapeutics' Times Interest Earned's 5-year high stood at -$1.67 during Q3 2021, with a 5-year trough of -$37.08 in Q2 2019.
  • Its 5-year average for Times Interest Earned is -$12.24, with a median of -$9.9 in 2020.
  • In the last 5 years, Sarepta Therapeutics' Times Interest Earned soared by 9736.31% in 2018 and then crashed by 43416.56% in 2022.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Times Interest Earned stood at -$19.23 in 2018, then plummeted by 42.73% to -$27.44 in 2019, then soared by 66.78% to -$9.11 in 2020, then dropped by 4.0% to -$9.48 in 2021, then tumbled by 68.52% to -$15.97 in 2022.
  • Its Times Interest Earned stands at -$15.97 for Q4 2022, versus -$8.91 for Q3 2022 and -$12.45 for Q2 2022.